Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $691000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 94.54% year-over-year to $691000.0, compared with a TTM value of $2.7 million through Dec 2025, down 87.89%, and an annual FY2025 reading of $14.1 million, down 36.15% over the prior year.
  • Depreciation & Amortization (CF) was $691000.0 for Q4 2025 at Roivant Sciences, down from $921000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $16.8 million in Q4 2023 and bottomed at $691000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $6.0 million, with a median of $4.9 million recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 205.35% in 2022, then tumbled 94.54% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $4.2 million in 2021, then surged by 205.35% to $12.9 million in 2022, then soared by 30.28% to $16.8 million in 2023, then decreased by 24.78% to $12.6 million in 2024, then crashed by 94.54% to $691000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ROIV at $691000.0 in Q4 2025, $921000.0 in Q3 2025, and $1.1 million in Q2 2025.